
  
    
      
        Background_NNP
        Gene_NNP expression_NN profiling_VBG using_VBG complementary_JJ DNA_NNP (_( cDNA_NN )_)
        microarrays_NNS is_VBZ being_VBG applied_VBN for_IN multiple_JJ purposes_NNS such_JJ as_IN
        defining_VBG the_DT taxonomy_NN of_IN different_JJ molecular_JJ subtypes_NNS of_IN
        human_JJ breast_NN and_CC other_JJ cancers_NNS [_NN 1_CD 2_CD 3_CD 4_CD 5_CD 6_CD 7_CD 8_CD 9_CD 10_CD ]_NN and_CC
        discovering_VBG biomarkers_NNS and_CC therapeutic_JJ targets_NNS [_NN 11_CD 12_CD ]_NN ._.
        A_DT limitation_NN of_IN the_DT use_NN of_IN this_DT technology_NN is_VBZ that_IN small_JJ
        specimens_NNS of_IN human_JJ tissue_NN ,_, such_JJ as_IN obtained_VBN by_IN core_NN needle_NN
        or_CC fine_NN needle_NN aspiration_NN (_( FNA_NNP )_) biopsies_NNS ,_, may_MD not_RB be_VB
        sufficient_JJ for_IN microarray_NN hybridization_NN using_VBG direct_JJ
        labelling_VBG protocols_NNS ._. Typical_JJ microarray_NN labelling_VBG
        procedures_NNS require_VBP 2_CD -_: 4_CD μg_NN poly_RB (_( A_DT )_) +_NN RNA_NNP or_CC 25_CD -_: 50_CD μg_NN total_JJ
        RNA_NNP per_IN cDNA_NN microarray_NN ._. This_DT amount_NN of_IN poly_RB (_( A_DT )_) +_NN RNA_NNP or_CC
        total_JJ RNA_NNP can_MD be_VB obtained_VBN from_IN samples_NNS of_IN human_JJ tissue_NN that_WDT
        weigh_VBP greater_JJR than_IN 50_CD -_: 100_CD mg_NN ._. However_RB ,_, core_NN needle_NN biopsies_NNS
        of_IN breast_NN cancers_NNS ,_, for_IN example_NN ,_, weigh_VB in_IN the_DT 10_CD -_: 25_CD mg_NN range_NN
        and_CC yield_VB only_RB 3_CD -_: 15_CD μg_NN of_IN total_JJ RNA_NNP ._. Small_JJ tumors_NNS
        identified_VBD using_VBG early_JJ detection_NN strategies_NNS may_MD thus_RB be_VB too_RB
        small_JJ to_TO excise_VB a_DT specimen_NN with_IN enough_RB RNA_NNP for_IN microarray_NN
        analysis_NN ._. A_DT pilot_NN study_NN by_IN Assersohn_NNP 
        et_CC al_NN ._. [_NN 13_CD ]_NN showed_VBD that_IN only_RB 15_CD %_NN of_IN
        FNA_NNP samples_NNS from_IN human_JJ breast_NN cancers_NNS produced_VBD sufficient_JJ
        mRNA_NN for_IN expression_NN array_NN analysis_NN ._. One_CD approach_NN to_TO low_JJ
        specimen_NN RNA_NNP input_NN has_VBZ been_VBN to_TO use_VB indirect_JJ labelling_VBG
        techniques_NNS to_TO increase_VB fluorescence_NN signal_NN intensity_NN ,_, such_JJ
        as_IN with_IN aminoallyl_NN nucleotides_NNS ._. Although_IN less_RBR expensive_JJ ,_, we_PRP
        and_CC other_JJ colleagues_NNS have_VBP found_VBN that_IN indirect_JJ labelling_VBG
        techniques_NNS are_VBP not_RB always_RB reliable_JJ compared_VBN to_TO direct_VB
        labelling_VBG methods_NNS ._. For_IN valuable_JJ tumor_NN specimen_NN ,_, reliability_NN
        is_VBZ paramount_JJ ._. A_DT very_RB recent_JJ report_NN used_VBD amino_JJ C_NNP 6_CD dT-modified_JJ
        random_JJ hexamers_NNS to_TO prime_JJ cDNA_NN synthesis_NN in_IN conjunction_NN with_IN
        aminoallyl-d_JJ UTP_NNP and_CC increased_VBN fluorescence_NN intensity_NN enough_RB
        such_JJ that_IN as_RB little_JJ as_IN 1_CD μg_NN of_IN total_JJ RNA_NNP from_IN cell_NN lines_NNS
        gave_VBD sufficient_JJ signal_NN for_IN cDNA_NN microarray_NN hybridization_NN [_NN
        14_CD ]_NN ._. The_DT reliability_NN of_IN this_DT method_NN with_IN human_JJ tumor_NN
        specimen_NN warrants_NNS further_JJ testing_NN ._.
        RNA_NNP amplification_NN techniques_NNS have_VBP been_VBN developed_VBN to_TO
        address_VB the_DT need_NN for_IN sufficient_JJ RNA_NNP from_IN tiny_JJ specimen_NN for_IN
        microarray_NN hybridization_NN ._. Other_JJ examples_NNS of_IN specimen_NN
        requiring_VBG amplification_NN for_IN genome-wide_JJ characterization_NN of_IN
        gene_NN expression_NN include_VBP purified_JJ populations_NNS of_IN cells_NNS
        obtained_VBN by_IN either_DT flow_NN cytometry_NN ,_, laser_NN capture_NN
        microdissection_NN ,_, breast_NN ductal_NN or_CC bronchial_NN lavage_NN ,_, or_CC
        microendoscopy_NN ._. Although_IN one_CD group_NN has_VBZ used_VBN unamplified_JJ
        total_JJ RNA_NNP extracted_VBD from_IN ~_NN 2_CD ×_NN 10_CD 4_CD microdissected_JJ cells_NNS for_IN
        hybridization_NN on_IN 5000_CD clone_NN membrane-based_JJ arrays_NNS [_NN 15_CD ]_NN ,_,
        most_JJS groups_NNS perform_VBP RNA_NNP amplification_NN for_IN this_DT purpose_NN [_NN 16_CD
        17_CD 18_CD ]_NN ,_, especially_RB when_WRB using_VBG high-density_JJ slide-based_JJ
        arrays_NNS ._.
        The_DT most_RBS commonly_RB used_VBN mechanism_NN for_IN RNA_NNP amplification_NN
        is_VBZ a_DT T_NN 7_CD based_VBN linear_JJ amplification_NN method_NN first_RB developed_VBN
        by_IN Van_NNP Gelder_NNP ,_, Eberwine_NNP and_CC coworkers_NNS [_NN 19_CD 20_CD 21_CD ]_NN ._. This_DT
        method_NN utilizes_NNS a_DT synthetic_JJ oligo_NN (_( dT_NN )_) primer_NN containing_VBG the_DT
        phage_NN T_NN 7_CD RNA_NNP polymerase_NN promoter_NN to_TO prime_JJ synthesis_NN of_IN
        first_JJ strand_NN cDNA_NN by_IN reverse_NN transcription_NN of_IN the_DT poly_RB (_( A_DT )_)
        +_NN RNA_NNP component_NN of_IN total_JJ RNA_NNP ._. Second_JJ strand_NN cDNA_NN is_VBZ
        synthesized_JJ by_IN degrading_JJ the_DT poly_RB (_( A_DT )_) +_NN RNA_NNP strand_NN with_IN RNase_NNP
        H_NNP ,_, followed_VBN by_IN second_JJ strand_NN synthesis_NN with_IN 
        E_NNP ._. coli_NNS DNA_NNP polymerase_NN I_PRP ._. Amplified_NNP
        antisense_NN RNA_NNP (_( aRNA_NN )_) is_VBZ obtained_VBN from_IN in_IN vitro_NN
        transcription_NN of_IN the_DT double-stranded_JJ cDNA_NN (_( ds_NNS cDNA_NN )_)
        template_NN using_VBG T_NN 7_CD RNA_NNP polymerase_NN ._. Several_JJ protocols_NNS based_VBN
        on_IN this_DT mechanism_NN have_VBP been_VBN developed_VBN and_CC used_VBN in_IN
        microarray_NN analyses_NNS [_NN 16_CD 22_CD 23_CD 24_CD 25_CD 26_CD 27_CD 28_CD ]_NN ._.
        In_IN spite_NN of_IN the_DT increasing_VBG use_NN of_IN T_NN 7_CD based_VBN linear_JJ
        amplification_NN techniques_NNS in_IN the_DT study_NN of_IN human_JJ disease_NN ,_,
        systematic_JJ evaluation_NN of_IN the_DT fidelity_NN and_CC the_DT
        reproducibility_NN of_IN amplification_NN mechanisms_NNS has_VBZ been_VBN
        limited_JJ ._. Such_JJ information_NN is_VBZ important_JJ to_TO determine_VB how_WRB
        well_RB the_DT amplified_VBN sample_NN resembles_VBZ the_DT unamplified_JJ sample_NN
        and_CC the_DT validity_NN of_IN applying_VBG this_DT technique_NN to_TO the_DT study_NN of_IN
        human_JJ tissues_NNS ._. A_DT study_NN by_IN Wang_NNP and_CC Miller_NNP 
        et_CC al_NN ._. [_NN 24_CD ]_NN described_VBD a_DT T_NN 7_CD based_VBN
        amplification_NN protocol_NN modified_VBN with_IN a_DT template-switching_JJ
        (_( TS_NNP )_) primer_NN used_VBN to_TO theoretically_RB generate_VB a_DT full-length_JJ ds_NNS
        cDNA_NN ._. The_DT gene_NN expression_NN of_IN amplified_VBN total_JJ RNA_NNP from_IN
        melanoma_NN cell_NN lines_NNS hybridized_JJ to_TO 2000_CD gene_NN microarrays_NNS was_VBD
        compared_VBN to_TO that_DT of_IN unamplified_JJ total_JJ or_CC poly_RB (_( A_DT )_) +_NN RNA_NNP using_VBG
        cluster_NN analysis_NN and_CC determining_VBG the_DT number_NN of_IN outlier_NN
        genes_NNS between_IN single_JJ experiments_NNS ._. Approximately_RB 3_CD -_: 6_CD %_NN of_IN
        genes_NNS were_VBD discordant_JJ outliers_NNS when_WRB analyzed_VBD using_VBG 3_CD -_: fold_VB
        or_CC greater_JJR expression_NN ratios_NNS in_IN at_IN least_JJS one_CD hybridization_NN
        and_CC compared_VBN between_IN total_JJ RNA_NNP ,_, mRNA_NN ,_, and_CC different_JJ amounts_NNS
        of_IN input_NN aRNA_NN ._. Hu_NNP and_CC co-workers_NNS [_NN 27_CD ]_NN compared_VBN amplified_VBN
        and_CC unamplified_JJ samples_NNS using_VBG total_JJ RNA_NNP obtained_VBD from_IN human_JJ
        glioma_NN cell_NN lines_NNS and_CC 2300_CD clone_NN microarrays_NNS (_( printed_VBN with_IN
        duplicates_NNS on_IN the_DT same_JJ array_NN )_) to_TO evaluate_VB a_DT similar_JJ T_NN 7_CD
        based_VBN protocol_NN with_IN a_DT TS_NNP mechanism_NN adopted_VBN from_IN Wang_NNP and_CC
        Miller_NNP 
        et_CC al_NN ._. [_NN 24_CD ]_NN ._. Their_PRP$ results_NNS were_VBD
        based_VBN on_IN nine_CD microarray_NN experiments_NNS and_CC showed_VBD concordance_NN
        between_IN amplified_VBN and_CC unamplified_JJ samples_NNS ,_, verifying_VBG four_CD
        expressed_VBD and_CC two_CD differentially_RB expressed_VBD genes_NNS using_VBG
        Northern_NNP and_CC Western_NNP blotting_VBG and_CC immunohistochemical_JJ
        assay_NN ._.
        Since_IN there_EX are_VBP multiple_JJ T_NN 7_CD based_VBN amplification_NN
        protocols_NNS in_IN use_NN ,_, questions_NNS remain_VBP regarding_VBG the_DT effects_NNS of_IN
        differences_NNS between_IN these_DT protocols_NNS and_CC how_WRB these_DT
        differences_NNS translate_VBP when_WRB applied_VBN to_TO solid_JJ tumors_NNS rather_RB
        than_IN cell_NN lines_NNS on_IN a_DT genome-wide_JJ scale_NN ._. A_DT study_NN from_IN Incyte_NNP
        Genomics_NNP [_NN 25_CD ]_NN examined_VBD gene_NN expression_NN of_IN kidney_NN vs_NNS ._.
        placenta_NN RNA_NNP and_CC RNA_NNP from_IN matched_VBN normal_JJ and_CC tumor_NN renal_JJ
        tissue_NN using_VBG their_PRP$ own_JJ T_NN 7_CD based_VBN amplification_NN kit_NN (_( not_RB
        employing_VBG a_DT TS_NNP primer_NN )_) and_CC 9700_CD clone_NN cDNA_NN microarrays_NNS ._.
        They_PRP found_VBD that_IN a_DT differential_NN expression_NN ratio_NN cut-off_JJ of_IN
        greater_JJR than_IN or_CC equal_JJ to_TO 2_CD -_: fold_VB produced_VBN excellent_JJ
        correlation_NN between_IN samples_NNS amplified_VBN with_IN different_JJ
        amounts_NNS of_IN input_NN poly_RB (_( A_DT )_) +_NN RNA_NNP but_CC that_IN a_DT 3_CD -_: fold_VB
        differential_NN expression_NN ratio_NN threshold_NN should_MD be_VB set_VBN for_IN
        comparing_VBG ratios_NNS between_IN amplified_VBN and_CC unamplified_JJ mRNA_NN ._.
        Decreasing_NNP the_DT input_NN of_IN tissue_NN lysate_NN increased_VBD gene_NN
        expression_NN discordance_NN between_IN amplified_VBN and_CC unamplified_JJ
        samples_NNS ._. As_IN more_RBR human_JJ tissues_NNS were_VBD tested_VBN ,_, single_JJ round_NN
        amplification_NN produced_VBD a_DT 200_CD -_: to_TO 500_CD -_: fold_VB yield_VB ,_, lower_JJR than_IN
        the_DT 700_CD -_: fold_VB yield_VB originally_RB found_VBD in_IN their_PRP$ study_NN and_CC
        lower_JJR than_IN yields_NNS reported_VBD in_IN amplification_NN studies_NNS using_VBG
        cell_NN cultures_NNS ._.
        The_DT differences_NNS between_IN several_JJ T_NN 7_CD based_VBN linear_JJ
        amplification_NN protocols_NNS are_VBP mainly_RB the_DT following_VBG :_: 1_CD ._.
        whether_IN a_DT template-switching_JJ mechanism_NN is_VBZ used_VBN in_IN the_DT
        synthesis_NN of_IN second_JJ strand_NN cDNA_NN ,_, 2_CD ._. what_WP enzymes_NNS are_VBP used_VBN
        in_IN the_DT synthesis_NN of_IN second_JJ strand_NN cDNA_NN ,_, 3_CD ._. how_WRB ds_NNS cDNA_NN is_VBZ
        purified_JJ (_( "_'' cleaned_VBN up_RP "_'' )_) prior_RB to_TO in_IN vitro_NN transcription_NN ,_,
        and_CC 4_CD ._. how_WRB in_IN vitro_NN transcription_NN is_VBZ performed_VBN ._. Information_NNP
        regarding_VBG the_DT effects_NNS of_IN these_DT differences_NNS on_IN the_DT fidelity_NN
        or_CC reproducibility_NN of_IN amplification_NN should_MD help_VB eliminate_VB
        both_DT unnecessary_JJ procedures_NNS and_CC those_DT actually_RB detrimental_JJ
        to_TO amplification_NN ._. Determination_NNP of_IN the_DT range_NN of_IN input_NN total_JJ
        RNA_NNP necessary_JJ to_TO achieve_VB reasonable_JJ fidelity_NN and_CC
        reproducibility_NN is_VBZ crucial_JJ for_IN researchers_NNS dealing_VBG with_IN
        very_RB small_JJ specimens_NNS of_IN human_JJ tissue_NN ._.
        To_TO answer_VB these_DT questions_NNS and_CC to_TO define_VB an_DT optimal_NN
        protocol_NN for_IN T_NN 7_CD based_VBN linear_JJ amplification_NN ,_, we_PRP carried_VBD out_RP
        a_DT series_NN of_IN amplification_NN reactions_NNS under_IN different_JJ
        conditions_NNS using_VBG total_JJ RNA_NNP isolated_VBD from_IN primary_JJ human_JJ
        breast_NN carcinomas_NNS ._. The_DT amplified_VBN samples_NNS were_VBD compared_VBN to_TO
        unamplified_JJ samples_NNS on_IN high-density_JJ cDNA_NN microarrays_NNS
        containing_VBG 41_CD ,_, 931_CD -_: 42_CD ,_, 602_CD clones_NNS ._. We_PRP evaluated_VBD the_DT effects_NNS
        of_IN TS_NNP primer_NN in_IN second_JJ strand_NN cDNA_NN synthesis_NN ,_, DNA_NNP ligase_NN
        activity_NN in_IN second_JJ strand_NN cDNA_NN synthesis_NN ,_, column_NN
        purification_NN of_IN ds_NNS cDNA_NN ,_, and_CC in_IN vitro_NN transcription_NN time_NN on_IN
        the_DT fidelity_NN and_CC reproducibility_NN of_IN amplification_NN and_CC the_DT
        yield_NN of_IN aRNA_NN ._. The_DT effect_NN of_IN diminishing_VBG amounts_NNS of_IN input_NN
        total_JJ RNA_NNP was_VBD also_RB tested_VBN ._.
      
      
        Results_NNS and_CC Discussion_NNP
        
          Variation_NNP in_IN cDNA_NN microarray_NN analysis_NN of_IN gene_NN
          expression_NN using_VBG unamplified_JJ poly_RB (_( A_DT )_) +_NN RNA_NNP
          In_IN order_NN to_TO assess_VB the_DT reproducibility_NN of_IN microarray_NN
          hybridization_NN using_VBG standard_JJ methods_NNS ,_, poly_RB (_( A_DT )_) +_NN RNA_NNP was_VBD
          isolated_VBN from_IN both_DT primary_JJ breast_NN carcinoma_NN BC_NNP 2_CD and_CC
          Universal_NNP Human_NNP Reference_NNP total_JJ RNA_NNP (_( Stratagene_NNP ®_NN )_) ._. The_DT
          BC_NNP 2_CD poly_RB (_( A_DT )_) +_NN RNA_NNP labelled_JJ with_IN Cy_NNP 5_CD and_CC the_DT reference_NN
          poly_RB (_( A_DT )_) +_NN RNA_NNP labelled_JJ with_IN Cy_NNP 3_CD were_VBD hybridized_JJ on_IN five_CD
          42_CD ,_, 000_CD clone_NN cDNA_NN microarrays_NNS ._. 16_CD ,_, 333_CD clones_NNS had_VBD a_DT signal_NN
          greater_JJR than_IN 50_CD %_NN above_IN background_NN on_IN all_DT five_CD arrays_NNS ._.
          Three_CD hybridizations_NNS were_VBD done_VBN on_IN the_DT same_JJ day_NN using_VBG
          arrays_NNS from_IN the_DT same_JJ print_NN batch_NN and_CC the_DT average_JJ
          correlation_NN coefficient_NN between_IN any_DT two_CD hybridizations_NNS
          was_VBD 0_CD ._. 97_CD ±_NN 0_CD ._. 01_CD ,_, demonstrating_VBG a_DT high_JJ reproducibility_NN
          between_IN parallel_JJ hybridizations_NNS done_VBN on_IN the_DT same_JJ day_NN ._.
          Another_DT two_CD hybridizations_NNS were_VBD performed_VBN using_VBG poly_RB (_( A_DT )_)
          +_NN RNA_NNP isolated_VBD from_IN BC_NNP 2_CD total_JJ RNA_NNP three_CD months_NNS later_RB and_CC a_DT
          different_JJ print_NN batch_NN of_IN microarrays_NNS ._. The_DT correlation_NN
          coefficient_NN between_IN these_DT two_CD arrays_NNS was_VBD 0_CD ._. 95_CD ,_, similar_JJ to_TO
          the_DT average_JJ correlation_NN coefficient_NN of_IN the_DT first_JJ three_CD
          arrays_NNS ._. However_RB ,_, when_WRB the_DT unamplified_JJ poly_RB (_( A_DT )_) +_NN RNA_NNP arrays_NNS
          performed_VBD weeks_NNS apart_RB from_IN different_JJ print_NN batches_NNS were_VBD
          compared_VBN ,_, the_DT average_JJ correlation_NN coefficient_NN dropped_VBD to_TO
          0_CD ._. 89_CD ±_NN 0_CD ._. 01_CD ,_, indicating_VBG that_IN experimental_JJ variations_NNS due_JJ
          to_TO differences_NNS in_IN microarray_NN printing_NN ,_, poly_RB (_( A_DT )_) +_NN RNA_NNP
          isolation_NN ,_, and_CC RNA_NNP labelling_VBG and_CC hybridization_NN contribute_VBP
          a_DT small_JJ but_CC detectable_JJ change_NN in_IN results_NNS ._.
          In_IN order_NN to_TO minimize_VB experimental_JJ variations_NNS ,_, we_PRP
          created_VBD a_DT virtual_JJ poly_RB (_( A_DT )_) +_NN RNA_NNP expression_NN array_NN that_IN
          idealizes_NNS the_DT gene_NN expression_NN of_IN sample_NN BC_NNP 2_CD by_IN using_VBG the_DT
          average_JJ expression_NN level_NN of_IN each_DT clone_NN over_IN multiple_JJ
          hybridizations_NNS ._. By_IN "_'' expression_NN level_NN "_'' we_PRP mean_VBP the_DT
          normalized_JJ log_NN (_( base_NN 2_LS )_) ratio_NN of_IN signal_NN intensities_NNS of_IN Cy_NNP 5_CD
          (_( experimental_JJ sample_NN )_) to_TO Cy_NNP 3_CD (_( reference_NN )_) fluorescence_NN ._.
          The_DT idealized_JJ expression_NN profile_NN from_IN the_DT poly_RB (_( A_DT )_) +_NN RNA_NNP
          virtual_JJ array_NN is_VBZ used_VBN as_IN our_PRP$ unamplified_JJ "_'' gold_NN standard_JJ "_''
          for_IN data_NNS analyses_NNS involving_VBG BC_NNP 2_CD ._. The_DT correlation_NN
          coefficient_NN between_IN each_DT individual_NN poly_RB (_( A_DT )_) +_NN RNA_NNP array_NN
          and_CC the_DT gold_NN standard_JJ ranges_NNS from_IN 0_CD ._. 95_CD -_: 0_CD ._. 97_CD ,_, similar_JJ to_TO
          that_DT observed_VBD between_IN hybridizations_NNS performed_VBN on_IN the_DT
          same_JJ day_NN ._. The_DT gold_NN standard_JJ virtual_JJ array_NN therefore_RB
          represents_VBZ well-measured_JJ gene_NN expression_NN in_IN the_DT primary_JJ
          tumor_NN and_CC minimizes_NNS individual_JJ experimental_JJ
          variations_NNS ._.
        
        
          Template-switching_NNP does_VBZ not_RB affect_VB the_DT fidelity_NN of_IN
          amplification_NN
          As_IN previously_RB mentioned_VBN ,_, a_DT protocol_NN based_VBN on_IN T_NN 7_CD based_VBN
          linear_JJ amplification_NN published_VBN by_IN Wang_NNP ,_, Miller_NNP and_CC
          coworkers_NNS [_NN 24_CD ]_NN incorporated_VBD a_DT TS_NNP mechanism_NN [_NN 29_CD ]_NN in_IN
          the_DT synthesis_NN of_IN second_JJ strand_NN cDNA_NN at_IN the_DT 5_CD '_POS end_NN in_IN
          order_NN to_TO generate_VB full-length_JJ ds_NNS cDNA_NN ._. This_DT was_VBD
          speculated_VBN to_TO be_VB of_IN advantage_NN in_IN the_DT hybridization_NN of_IN
          unmapped_JJ sequences_NNS spotted_VBD on_IN arrays_NNS and_CC to_TO enable_VB higher_JJR
          temperature_NN cDNA_NN synthesis_NN that_WDT would_MD enhance_VB sequence_NN
          specificity_NN ._. However_RB ,_, no_DT experimental_JJ evidence_NN was_VBD
          provided_VBN to_TO support_VB the_DT idea_NN that_IN the_DT TS_NNP mechanism_NN
          increases_VBZ the_DT fidelity_NN of_IN amplification_NN ._.
          To_TO determine_VB whether_IN the_DT addition_NN of_IN TS_NNP primer_NN
          improves_VBZ the_DT fidelity_NN of_IN amplification_NN ,_, we_PRP compared_VBD gene_NN
          expression_NN profiles_NNS of_IN aRNA_NN amplified_VBN in_IN the_DT presence_NN or_CC
          absence_NN of_IN TS_NNP primer_NN with_IN expression_NN profiles_NNS of_IN
          unamplified_JJ poly_RB (_( A_DT )_) +_NN RNA_NNP ._. Total_NNP RNA_NNP isolated_VBD from_IN primary_JJ
          breast_NN carcinoma_NN BC_NNP 91_CD and_CC reference_NN total_JJ RNA_NNP were_VBD
          amplified_VBN with_IN or_CC without_IN TS_NNP primer_NN using_VBG the_DT Wang-_NNP Miller_NNP
          protocol_NN [_NN 24_CD ]_NN ,_, except_IN that_DT aRNA_NN was_VBD purified_JJ using_VBG an_DT
          RNeasy_NNP ®_NN kit_NN (_( Qiagen_NNP ®_NN )_) ._. A_DT virtual_JJ "_'' gold_NN standard_JJ "_'' poly_RB (_( A_DT )_)
          +_NN RNA_NNP array_NN was_VBD created_VBN for_IN BC_NNP 91_CD using_VBG the_DT average_JJ
          expression_NN level_NN of_IN four_CD hybridization_NN replicates_NNS of_IN
          unamplified_JJ poly_RB (_( A_DT )_) +_NN RNA_NNP ._. A_DT "_'' virtual_JJ correlation_NN
          coefficient_NN "_'' for_IN a_DT given_VBN amplification_NN protocol_NN was_VBD
          obtained_VBN by_IN comparing_VBG the_DT virtual_JJ amplified_VBN array_NN
          (_( averaged_VBD expression_NN level_NN for_IN each_DT clone_NN from_IN multiple_JJ
          amplified_VBN samples_NNS )_) to_TO the_DT virtual_JJ gold_NN standard_JJ
          unamplified_JJ array_NN for_IN BC_NNP 91_CD ._. To_TO determine_VB the_DT correlation_NN
          between_IN individual_JJ amplified_VBN samples_NNS and_CC the_DT gold_NN
          standard_JJ ,_, an_DT "_'' average_JJ correlation_NN coefficient_NN "_'' for_IN a_DT
          given_VBN amplification_NN protocol_NN was_VBD also_RB calculated_VBN (_( the_DT sum_NN
          of_IN correlation_NN coefficients_NNS of_IN individual_JJ amplified_VBN
          samples_NNS with_IN the_DT gold_NN standard_JJ divided_VBN by_IN the_DT number_NN of_IN
          amplified_VBN samples_NNS tested_VBN for_IN each_DT condition_NN )_) ._.
          As_IN shown_VBN in_IN Table_NNP 1_CD ,_, using_VBG aRNA_NN amplified_VBN from_IN total_JJ
          RNA_NNP as_IN reference_NN ,_, the_DT expression_NN profiles_NNS obtained_VBN in_IN the_DT
          absence_NN of_IN TS_NNP primer_NN correlated_JJ with_IN the_DT gold_NN standard_JJ
          slightly_RB better_JJR than_IN in_IN the_DT presence_NN of_IN TS_NNP primer_NN ,_,
          although_IN the_DT difference_NN was_VBD not_RB statistically_RB
          significant_JJ ._. When_WRB poly_RB (_( A_DT )_) +_NN RNA_NNP rather_RB than_IN total_JJ RNA_NNP was_VBD
          amplified_VBN as_IN reference_NN ,_, the_DT correlation_NN with_IN the_DT gold_NN
          standard_NN was_VBD slightly_RB ,_, but_CC not_RB statistically_RB
          significantly_RB ,_, better_JJR with_IN TS_NNP primer_NN (_( Table_NNP 1_LS )_) ._. The_DT
          correlation_NN coefficient_NN using_VBG aRNA_NN amplified_VBN from_IN total_JJ
          RNA_NNP as_IN reference_NN is_VBZ higher_JJR than_IN using_VBG aRNA_NN amplified_VBN from_IN
          poly_RB (_( A_DT )_) +_NN RNA_NNP as_IN reference_NN regardless_RB of_IN whether_IN TS_NNP primer_NN
          is_VBZ used_VBN ._. This_DT suggests_VBZ that_IN when_WRB total_JJ RNA_NNP from_IN a_DT tumor_NN
          sample_NN is_VBZ amplified_VBN for_IN microarray_NN analysis_NN ,_, the_DT
          reference_NN RNA_NNP should_MD also_RB be_VB amplified_VBN from_IN total_JJ
          RNA_NNP ._.
          The_DT yield_NN of_IN aRNA_NN amplified_VBN from_IN BC_NNP 91_CD total_JJ RNA_NNP using_VBG
          different_JJ protocols_NNS is_VBZ shown_VBN in_IN Table_NNP 2_CD ._. Assuming_VBG 1_CD %_NN of_IN
          the_DT total_JJ RNA_NNP is_VBZ poly_RB (_( A_DT )_) +_NN RNA_NNP ,_, a_DT 253_CD and_CC 370_CD -_: fold_VB
          amplification_NN was_VBD observed_VBN in_IN the_DT presence_NN and_CC absence_NN of_IN
          TS_NNP primer_NN ,_, respectively_RB ._. The_DT yield_NN of_IN aRNA_NN amplified_VBN from_IN
          total_JJ RNA_NNP which_WDT are_VBP generated_VBN from_IN cultured_JJ cell_NN lines_NNS
          was_VBD 2_CD -_: to_TO 3_CD -_: fold_VB higher_JJR than_IN when_WRB the_DT primary_JJ tumor_NN total_JJ
          RNA_NNP was_VBD amplified_VBN (_( data_NNS not_RB shown_VBN )_) ._.
          These_DT experiments_NNS demonstrate_VBP that_IN the_DT TS_NNP mechanism_NN
          does_VBZ not_RB increase_VB the_DT fidelity_NN of_IN amplification_NN ,_, and_CC
          therefore_RB can_MD be_VB eliminated_VBN from_IN the_DT protocol_NN ._. The_DT
          reasons_NNS for_IN the_DT limited_JJ effect_NN of_IN the_DT TS_NNP mechanism_NN on_IN the_DT
          correlation_NN coefficients_NNS probably_RB are_VBP :_: 1_LS )_) the_DT second_JJ
          strand_NN cDNA_NN synthesis_NN primed_VBN by_IN the_DT TS_NNP primer_NN probably_RB
          represents_VBZ a_DT small_JJ fraction_NN ,_, while_IN the_DT majority_NN of_IN the_DT
          synthesis_NN is_VBZ self-primed_JJ or_CC primed_VBN by_IN small_JJ pieces_NNS of_IN RNA_NNP
          generated_VBN by_IN RNase_NNP H_NNP ;_: and_CC 2_LS )_) adding_VBG a_DT few_JJ base_NN pairs_NNS to_TO
          the_DT ds_NNS cDNA_NN prior_RB to_TO in_IN vitro_NN transcription_NN does_VBZ not_RB
          change_VB the_DT aRNA_NN significantly_RB enough_RB to_TO affect_VB the_DT array_NN
          hybridization_NN ._.
        
        
          DNA_NN ligase_NN activity_NN is_VBZ not_RB required_VBN for_IN
          amplification_NN
          Amplification_NNP protocols_NNS that_WDT do_VBP not_RB include_VB DNA_NNP ligase_NN
          in_IN second_JJ strand_NN cDNA_NN synthesis_NN generate_VBP the_DT same_JJ length_NN
          aRNA_NN (_( ranging_VBG from_IN 0_CD ._. 2_CD kb_NN to_TO 6_CD kb_NN ,_, data_NNS not_RB shown_VBN )_) as_IN
          generated_VBN from_IN a_DT widely_RB used_VBN T_NN 7_CD based_VBN amplification_NN
          protocol_NN developed_VBN by_IN Affymetrix_NNP ®_NN [_NN 26_CD ]_NN which_WDT uses_VBZ 
          E_NNP ._. coli_NNS DNA_NNP ligase_NN ._. The_DT correlation_NN
          coefficient_NN between_IN amplified_VBN and_CC unamplified_JJ sample_NN and_CC
          the_DT yield_NN of_IN aRNA_NN amplified_VBN without_IN DNA_NNP ligase_NN are_VBP high_JJ
          enough_RB to_TO suggest_VB that_IN DNA_NNP ligase_NN activity_NN is_VBZ not_RB
          necessary_JJ for_IN RNA_NNP amplification_NN in_IN microarray_NN analysis_NN ._.
          For_IN confirmation_NN ,_, we_PRP omitted_VBD DNA_NNP ligase_NN from_IN the_DT protocol_NN
          developed_VBN by_IN Affymetrix_NNP ®_NN and_CC compared_VBD the_DT expression_NN
          profiles_NNS of_IN the_DT resulting_VBG aRNA_NN to_TO aRNA_NN obtained_VBD using_VBG the_DT
          standard_JJ Affymetrix_NNP ®_NN protocol_NN that_WDT includes_VBZ DNA_NNP ligase_NN ._.
          The_DT correlation_NN coefficient_NN between_IN amplified_VBN and_CC
          unamplified_JJ samples_NNS is_VBZ slightly_RB higher_JJR in_IN the_DT absence_NN of_IN
          ligase_NN (_( Table_NNP 3_LS )_) ,_, supporting_VBG our_PRP$ previous_JJ conclusion_NN that_DT
          ligase_NN is_VBZ not_RB required_VBN for_IN total_JJ RNA_NNP amplification_NN in_IN
          cDNA_NN microarray_NN analysis_NN ._. However_RB ,_, the_DT yield_NN of_IN aRNA_NN is_VBZ
          higher_JJR when_WRB ligase_NN is_VBZ used_VBN ,_, suggesting_VBG that_DT ligase_NN may_MD
          play_VB a_DT role_NN in_IN improving_VBG the_DT efficiency_NN of_IN
          amplification_NN ._.
        
        
          Column_NNP cleanup_NN of_IN ds_NNS cDNA_NN does_VBZ not_RB improve_VB the_DT
          fidelity_NN of_IN amplification_NN ,_, but_CC decreases_VBZ the_DT yield_NN of_IN
          aRNA_NN
          In_IN the_DT Wang-_NNP Miller_NNP protocol_NN [_NN 24_CD ]_NN ,_, ds_NNS cDNA_NN is_VBZ
          purified_JJ using_VBG a_DT Bio-_NNP 6_CD column_NN (_( Bio-_NNP Rad_NNP )_) ._. A_DT drawback_NN to_TO
          this_DT method_NN is_VBZ that_IN the_DT cDNA_NN is_VBZ eluted_JJ with_IN a_DT large_JJ
          volume_NN and_CC needs_VBZ to_TO be_VB concentrated_VBN into_IN a_DT much_RB smaller_JJR
          volume_NN by_IN lyophilization_NN prior_RB to_TO in_IN vitro_NN transcription_NN ._.
          This_DT is_VBZ a_DT time-consuming_JJ step_NN ,_, especially_RB when_WRB large_JJ
          numbers_NNS of_IN samples_NNS are_VBP processed_VBN ._. To_TO eliminate_VB the_DT
          lyophilization_NN step_NN from_IN the_DT protocol_NN ,_, we_PRP used_VBD an_DT
          alternative_NN column-the_JJ Sephadex_NNP ™_NN G-_NNP 50_CD column-to_JJ filter_NN
          out_IN free_JJ nucleotides_NNS from_IN the_DT ds_NNS cDNA_NN after_IN completion_NN of_IN
          the_DT second_JJ strand_NN synthesis_NN reaction_NN ._. The_DT ds_NNS cDNA_NN is_VBZ then_RB
          precipitated_VBD following_VBG phenol-chloroform_JJ extraction_NN and_CC
          re-suspended_JJ in_IN proper_JJ volume_NN for_IN in_IN vitro_NN transcription_NN ._.
          The_DT correlation_NN coefficient_NN between_IN amplified_VBN and_CC
          unamplified_JJ samples_NNS and_CC the_DT yield_NN of_IN aRNA_NN using_VBG this_DT less_RBR
          time-consuming_JJ modification_NN are_VBP similar_JJ to_TO that_DT using_VBG the_DT
          Wang-_NNP Miller_NNP protocol_NN (_( Tables_NNP 1_CD and_CC 2_LS )_) ._.
          We_PRP further_JJ explored_JJ the_DT question_NN of_IN what_WP effects_VBZ the_DT
          ds_NNS cDNA_NN column_NN cleanup_NN step_NN itself_PRP had_VBD on_IN amplification_NN ._.
          We_PRP amplified_VBN total_JJ RNA_NNP from_IN tumor_NN BC_NNP 2_CD ,_, either_CC with_IN or_CC
          without_IN the_DT cleanup_NN step_NN of_IN Sephadex_NNP ™_NN G-_NNP 50_CD ._. Seven_CD
          amplifications_NNS were_VBD done_VBN on_IN different_JJ dates_NNS with_IN the_DT
          Sephadex_NNP ™_NN G-_NNP 50_CD column_NN and_CC five_CD amplifications_NNS were_VBD done_VBN
          without_IN this_DT cleanup_NN step_NN ._. Both_DT the_DT virtual_JJ and_CC the_DT
          average_JJ correlation_NN coefficients_NNS using_VBG the_DT column_NN are_VBP
          slightly_RB lower_JJR than_IN without_IN it_PRP (_( Table_NNP 4_LS )_) ,_, suggesting_VBG that_IN
          the_DT column_NN cleanup_NN does_VBZ not_RB improve_VB the_DT fidelity_NN of_IN
          amplification_NN ._. Moreover_RB ,_, the_DT yield_NN of_IN aRNA_NN is_VBZ
          significantly_RB higher_JJR without_IN the_DT column_NN purification_NN of_IN
          ds_NNS cDNA_NN ,_, suggesting_VBG some_DT loss_NN of_IN ds_NNS cDNA_NN on_IN the_DT column_NN ._.
          Since_IN the_DT column_NN had_VBD a_DT negative_JJ effect_NN on_IN amplification_NN
          by_IN decreasing_VBG the_DT yield_NN of_IN aRNA_NN without_IN improving_VBG the_DT
          fidelity_NN of_IN amplification_NN ,_, we_PRP eliminated_VBD this_DT step_NN from_IN
          our_PRP$ protocol_NN ._.
        
        
          Effect_NN of_IN in_IN vitro_NN transcription_NN time_NN on_IN the_DT
          fidelity_NN of_IN RNA_NNP amplification_NN
          To_TO determine_VB the_DT effect_NN of_IN in_IN vitro_NN transcription_NN time_NN
          on_IN amplification_NN ,_, duplicate_VB reactions_NNS were_VBD performed_VBN at_IN
          37_CD °_NN C_NNP for_IN 2_CD ,_, 3_CD ,_, 4_CD ,_, 5_CD and_CC 6_CD hours_NNS ._. Two_CD additional_JJ 5_CD -_: hour_NN
          incubation_NN reactions_NNS were_VBD stored_VBN at_IN 4_CD °_NN C_NNP overnight_JJ to_TO
          determine_VB the_DT effect_NN of_IN low_JJ temperature_NN incubation_NN on_IN
          amplification_NN ._. The_DT virtual_JJ correlation_NN coefficient_NN is_VBZ
          slightly_RB higher_JJR for_IN the_DT 5_CD -_: hour_NN incubation_NN at_IN 37_CD °_NN C_NNP (_( Figure_NN
          1_CD A_DT )_) ._. However_RB ,_, in_IN vitro_NN transcription_NN for_IN 5_CD hours_NNS at_IN 37_CD °_NN C_NNP
          plus_CC overnight_JJ incubation_NN at_IN 4_CD °_NN C_NNP gives_VBZ the_DT highest_JJS yield_NN
          of_IN aRNA_NN (_( Figure_NN 1_CD B_NNP )_) ._. Since_IN the_DT yield_NN of_IN aRNA_NN at_IN any_DT time_NN
          point_NN is_VBZ sufficient_JJ for_IN multiple_JJ hybridizations_NNS ,_, we_PRP
          decided_VBD to_TO use_VB 5_CD -_: hour_NN incubation_NN at_IN 37_CD °_NN C_NNP for_IN all_DT
          subsequent_JJ amplifications_NNS ._.
        
        
          Evaluation_NNP of_IN the_DT fidelity_NN of_IN T_NN 7_CD based_VBN linear_JJ
          amplification_NN protocols_NNS
          To_TO systematically_RB evaluate_VB the_DT fidelity_NN of_IN T_NN 7_CD based_VBN
          amplification_NN ,_, we_PRP compared_VBD the_DT correlation_NN coefficient_NN
          obtained_VBN from_IN four_CD different_JJ protocols_NNS ._. The_DT correlation_NN
          coefficients_NNS of_IN individual_JJ samples_NNS amplified_VBN using_VBG
          different_JJ protocols_NNS with_IN the_DT gold_NN standard_JJ range_NN from_IN
          0_CD ._. 74_CD -_: 0_CD ._. 86_CD (_( Figure_NN 2_LS )_) ._. The_DT scatter_NN plots_NNS comparing_VBG the_DT
          gene_NN expression_NN of_IN the_DT virtual_JJ amplified_VBN samples_NNS for_IN each_DT
          protocol_NN with_IN the_DT unamplified_JJ gold_NN standard_JJ are_VBP shown_VBN in_IN
          Figure_NN 3_CD ,_, with_IN the_DT virtual_JJ correlation_NN coefficients_NNS
          ranging_VBG from_IN 0_CD ._. 83_CD -_: 0_CD ._. 86_CD ._. The_DT differences_NNS in_IN correlations_NNS
          obtained_VBD using_VBG different_JJ protocols_NNS are_VBP not_RB statistically_RB
          different_JJ by_IN Student_NNP 's_POS 
          t_NN -_: test_NN ,_, demonstrating_VBG that_IN
          differences_NNS in_IN gene_NN expression_NN for_IN samples_NNS amplified_VBN
          using_VBG different_JJ protocols_NNS are_VBP minor_JJ ._.
          Our_PRP$ results_NNS also_RB suggest_VBP that_IN the_DT level_NN of_IN bias_NN
          introduced_VBN into_IN gene_NN expression_NN profiling_VBG by_IN
          amplification_NN is_VBZ relatively_RB low_JJ ;_: expression_NN profiles_NNS
          obtained_VBD using_VBG aRNA_NN provide_VBP a_DT close_JJ approximation_NN of_IN the_DT
          true_JJ expression_NN profile_NN of_IN the_DT original_JJ sample_NN ._. To_TO assess_VB
          the_DT biases_NNS of_IN amplification_NN quantitatively_RB ,_, we_PRP calculated_VBD
          the_DT number_NN and_CC percentage_NN of_IN genes_NNS with_IN expression_NN level_NN
          change_NN by_IN 4_CD -_: or_CC 2_CD -_: fold_VB after_IN amplification_NN ._. The_DT biases_NNS of_IN
          amplification_NN by_IN different_JJ protocols_NNS are_VBP similar_JJ ._.
          Specifically_RB ,_, less_JJR than_IN 0_CD ._. 2_CD %_NN of_IN 11_CD ,_, 123_CD genes_NNS (_( 12_CD -_: 15_CD
          genes_NNS )_) changed_VBN their_PRP$ expression_NN level_NN by_IN 4_CD -_: fold_VB or_CC
          greater_JJR and_CC less_JJR than_IN 6_CD %_NN (_( 306_CD -_: 594_CD genes_NNS )_) changed_VBN
          expression_NN by_IN 2_CD -_: fold_VB or_CC greater_JJR after_IN amplification_NN ._. With_IN
          the_DT Jeffrey_NNP lab_NN protocol_NN ,_, less_JJR than_IN 4_CD %_NN of_IN genes_NNS showed_VBD
          changes_NNS in_IN expression_NN level_NN by_IN 2_CD -_: fold_VB or_CC greater_JJR ._. Of_IN the_DT
          genes_NNS that_WDT changed_VBD ,_, 7_CD genes_NNS and_CC 139_CD genes_NNS changed_VBD their_PRP$
          expression_NN in_IN all_DT four_CD protocols_NNS in_IN the_DT same_JJ direction_NN
          greater_JJR than_IN 4_CD -_: fold_VB and_CC 2_CD -_: fold_VB ,_, respectively_RB ._. Also_RB ,_, the_DT
          virtual_JJ correlation_NN coefficients_NNS between_IN different_JJ
          protocols_NNS are_VBP high_JJ (_( average_JJ 0_CD ._. 95_CD )_) (_( Figure_NN 3_LS )_) ,_, suggesting_VBG
          that_IN slight_JJ differences_NNS in_IN protocols_NNS based_VBN on_IN T_NN 7_CD linear_JJ
          amplification_NN mechanism_NN do_VBP not_RB affect_VB the_DT correlation_NN of_IN
          amplified_VBN samples_NNS to_TO unamplified_JJ samples_NNS ._. These_DT results_NNS
          suggest_VBP the_DT conclusion_NN that_DT aRNA_NN provides_VBZ a_DT close_JJ
          approximation_NN of_IN the_DT true_JJ expression_NN profile_NN of_IN the_DT
          original_JJ sample_NN ._.
          We_PRP present_JJ here_RB a_DT components_NNS of_IN variance_NN model_NN for_IN
          explaining_VBG the_DT different_JJ sources_NNS of_IN variation_NN in_IN the_DT
          amplification_NN protocols_NNS (_( see_VB Statistical_NNP Appendix_NNP ,_,
          additional_JJ file_NN 1_LS )_) ._. The_DT expression_NN measurement_NN for_IN a_DT gene_NN
          for_IN a_DT specific_JJ array_NN /_NN protocol_NN /_NN sample_NN can_MD be_VB broken_VBN down_RB
          as_IN
          Additional_JJ File_NNP 1_CD
          Statistical_NNP Appendix_NNP
          Click_NNP here_RB for_IN file_NN
          X_NNP =_SYM Z_NNP +_NN e_SYM ,_, where_WRB
          X_NNP is_VBZ the_DT measured_VBN expression_NN value_NN
          Z_NNP is_VBZ the_DT "_'' true_JJ "_'' expression_NN that_WDT does_VBZ not_RB change_VB under_IN
          replication_NN ,_, and_CC
          e_SYM is_VBZ the_DT measurement_NN error_NN that_WDT does_VBZ change_NN under_IN
          replication_NN ._.
          While_IN we_PRP cannot_NN estimate_NN Z_NNP and_CC e_SYM directly_RB ,_, we_PRP can_MD
          estimate_VB their_PRP$ variances_NNS from_IN the_DT data_NNS ._. For_IN the_DT four_CD
          different_JJ amplified_VBN protocols_NNS and_CC the_DT unamplified_JJ arrays_NNS ,_,
          the_DT relevant_JJ variances_NNS are_VBP estimated_VBN in_IN Table_NNP 5_CD ._. The_DT
          variance_NN of_IN the_DT true_JJ expression_NN (_( Var_NNP Z_NNP )_) ranges_NNS from_IN
          0_CD ._. 623_CD -_: 0_CD ._. 661_CD for_IN the_DT amplified_VBN protocols_NNS and_CC is_VBZ 0_CD ._. 726_CD for_IN
          the_DT unamplified_JJ arrays_NNS ._. The_DT variance_NN of_IN the_DT measurement_NN
          error_NN (_( Var_NNP e_SYM )_) ranges_NNS from_IN 0_CD ._. 055_CD -_: 0_CD ._. 102_CD for_IN the_DT amplified_VBN
          protocols_NNS and_CC is_VBZ 0_CD ._. 059_CD for_IN the_DT unamplified_JJ arrays_NNS ._. The_DT
          estimates_NNS of_IN Var_NNP Z_NNP were_VBD obtained_VBN by_IN averaging_VBG the_DT
          pairwise_NN covariances_NNS of_IN the_DT replicates_NNS within_IN each_DT
          protocol_NN ,_, and_CC the_DT estimates_NNS of_IN Var_NNP e_SYM by_IN using_VBG the_DT
          within-protocol_JJ variance_NN ._. (_( While_IN the_DT variance_NN of_IN a_DT
          collection_NN of_IN numbers_NNS measures_NNS how_WRB much_JJ they_PRP vary_VBP about_IN
          their_PRP$ mean_NN ,_, the_DT covariance_NN of_IN two_CD sets_NNS of_IN numbers_NNS
          measures_NNS how_WRB much_JJ they_PRP vary_VBP with_IN respect_NN to_TO each_DT other_JJ ._.
          See_VB Statistical_NNP Appendix_NNP for_IN more_JJR details_NNS )_) ._. We_PRP notice_VBP
          that_IN Var_NNP Z_NNP for_IN unamplified_JJ poly_RB (_( A_DT )_) +_NN RNA_NNP is_VBZ larger_JJR than_IN
          all_DT of_IN the_DT others_NNS ,_, indicating_VBG a_DT dampening_VBG effect_NN on_IN gene_NN
          expression_NN by_IN amplification_NN ._. Measurement_NNP error_NN variance_NN
          is_VBZ lowest_JJS for_IN the_DT Jeffrey_NNP lab_NN protocol_NN ._.
          The_DT covariances_NNS between_IN the_DT different_JJ Zs_NNP for_IN the_DT
          different_JJ methods_NNS (_( estimated_VBN from_IN the_DT virtual_JJ arrays_NNS )_) are_VBP
          shown_VBN in_IN Table_NNP 6_CD ._. The_DT off-diagonal_JJ elements_NNS of_IN Table_NNP 6_CD are_VBP
          the_DT covariances_NNS ;_: the_DT diagonal_NN elements_NNS are_VBP the_DT variances_NNS
          of_IN the_DT virtual_JJ arrays_NNS ._. We_PRP notice_VBP that_IN covariances_NNS among_IN
          the_DT amplified_VBN protocols_NNS ,_, which_WDT range_VBP from_IN 0_CD ._. 62_CD to_TO 0_CD ._. 66_CD ,_,
          are_VBP higher_JJR than_IN their_PRP$ covariances_NNS with_IN the_DT unamplified_JJ
          arrays_NNS ,_, which_WDT range_VBP between_IN 0_CD ._. 57_CD and_CC 0_CD ._. 61_CD ._. Furthermore_RB ,_,
          the_DT variances_NNS of_IN the_DT amplified_VBN protocols_NNS (_( 0_CD ._. 63_CD to_TO 0_CD ._. 68_CD )_)
          are_VBP lower_JJR than_IN that_DT of_IN the_DT unamplifed_JJ (_( 0_CD ._. 74_CD )_) ._.
          This_DT suggests_VBZ the_DT following_VBG further_JJ breakdown_NN :_:
          Z_NNP =_SYM Zc_NNP +_NN Zs_NNP ,_, where_WRB
          Zc_NNP is_VBZ a_DT common_JJ expression_NN component_NN ,_, with_IN variance_NN
          about_IN 0_CD ._. 6_CD ,_, and_CC
          Zs_NNP is_VBZ a_DT specific_JJ expression_NN component_NN ,_, with_IN variance_NN
          about_IN 0_CD ._. 04_CD for_IN the_DT amplified_VBN arrays_NNS and_CC 0_CD ._. 14_CD for_IN the_DT
          unamplified_JJ arrays_NNS ._.
          Therefore_RB ,_, the_DT amplified_VBN expression_NN values_NNS for_IN genes_NNS
          on_IN an_DT array_NN are_VBP largely_RB the_DT same_JJ as_IN on_IN the_DT unamplified_JJ
          array_NN ._. The_DT component_NN of_IN variation_NN in_IN which_WDT they_PRP differ_VBP
          appears_VBZ to_TO be_VB common_JJ for_IN all_DT amplified_VBN protocols_NNS ,_, and_CC
          shows_VBZ a_DT much_RB higher_JJR variance_NN in_IN the_DT unamplified_JJ arrays_NNS ._.
          The_DT effect_NN of_IN amplification_NN can_MD be_VB summarized_VBD by_IN saying_VBG
          that_IN it_PRP has_VBZ a_DT dampening_VBG effect_NN on_IN the_DT true_JJ expression_NN of_IN
          some_DT genes_NNS (_( decreased_VBD variance_NN in_IN gene_NN expression_NN -_: see_VB
          Figure_NN 4_LS )_) ._.
          A_DT recent_JJ report_NN compared_VBN amplified_VBN expression_NN profiles_NNS
          of_IN different_JJ primary_JJ breast_NN tumors_NNS using_VBG Affymetrix_NNP
          ®_NN arrays_NNS [_NN 30_CD ]_NN ._. Unger_NNP 
          et_CC al_NN ._. found_VBD that_IN correlation_NN
          coefficients_NNS between_IN gene_NN expressions_NNS in_IN different_JJ tumors_NNS
          revealed_VBN by_IN aRNA_NN ranged_VBD between_IN 0_CD ._. 71_CD -_: 0_CD ._. 89_CD ._. However_RB ,_, gene_NN
          expression_NN was_VBD not_RB measured_VBN using_VBG unamplified_JJ poly_RB (_( A_DT )_)
          +_NN RNA_NNP from_IN these_DT different_JJ tumors_NNS ,_, raising_VBG the_DT question_NN of_IN
          whether_IN the_DT observed_VBN fairly_RB high_JJ correlation_NN between_IN
          diverse_JJ tumors_NNS was_VBD due_JJ to_TO amplification_NN bias_NN ._. To_TO answer_VB
          this_DT question_NN ,_, we_PRP compared_VBD the_DT correlation_NN coefficients_NNS
          between_IN gene_NN expression_NN profiles_NNS of_IN different_JJ tumors_NNS
          determined_VBN either_CC with_IN unamplified_JJ poly_RB (_( A_DT )_) +_NN RNA_NNP or_CC aRNA_NN
          amplified_VBN using_VBG our_PRP$ protocol_NN (_( Table_NNP 7_CD )_) ._. The_DT correlation_NN
          coefficients_NNS between_IN BC_NNP 2_CD and_CC BC_NNP 91_CD measured_VBN using_VBG poly_RB (_( A_DT )_)
          +_NN RNA_NNP or_CC aRNA_NN are_VBP the_DT same_JJ ,_, 0_CD ._. 55_CD ._. Moreover_RB ,_, the_DT
          correlation_NN between_IN differences_NNS in_IN gene_NN expression_NN
          between_IN amplified_VBN and_CC unamplified_JJ samples_NNS for_IN different_JJ
          tumors_NNS is_VBZ weak_JJ (_( Figure_NN 4_LS )_) ,_, suggesting_VBG that_IN genes_NNS that_WDT
          differ_VBP through_IN amplification_NN depend_VB on_IN the_DT sample_NN rather_RB
          than_IN on_IN systematic_JJ changes_NNS from_IN amplification_NN ._. Our_PRP$
          results_NNS demonstrate_VBP that_IN different_JJ primary_JJ breast_NN tumors_NNS
          are_VBP not_RB closely_RB related_VBN to_TO each_DT other_JJ in_IN gene_NN expression_NN
          profiles_NNS ,_, and_CC amplification_NN does_VBZ not_RB affect_VB the_DT
          correlation_NN of_IN gene_NN expression_NN between_IN different_JJ tumors_NNS ._.
          Amplification_NNP is_VBZ therefore_RB suitable_JJ for_IN comparison_NN of_IN
          gene_NN expression_NN profiles_NNS among_IN large_JJ sample_NN sets_NNS ._.
        
        
          Evaluation_NNP of_IN reproducibility_NN of_IN T_NN 7_CD based_VBN linear_JJ
          amplification_NN
          Another_DT important_JJ aspect_NN of_IN RNA_NNP amplification_NN is_VBZ the_DT
          degree_NN of_IN reproducibility_NN ._. To_TO evaluate_VB this_DT ,_, we_PRP
          calculated_VBD the_DT correlation_NN coefficients_NNS between_IN
          individual_JJ amplified_VBN samples_NNS ._. The_DT correlation_NN
          coefficients_NNS between_IN individual_JJ hybridizations_NNS done_VBN on_IN
          the_DT same_JJ day_NN for_IN poly_RB (_( A_DT )_) +_NN RNA_NNP averaged_VBD 0_CD ._. 97_CD and_CC for_IN aRNA_NN
          amplified_VBN on_IN the_DT same_JJ day_NN averaged_VBD from_IN 0_CD ._. 91_CD -_: 0_CD ._. 98_CD (_( Table_NNP
          8_CD )_) ._. The_DT correlation_NN coefficients_NNS between_IN individual_JJ
          hybridizations_NNS done_VBN on_IN different_JJ days_NNS averaged_VBD 0_CD ._. 89_CD for_IN
          poly_RB (_( A_DT )_) +_NN RNA_NNP and_CC 0_CD ._. 85_CD -_: 0_CD ._. 90_CD for_IN aRNA_NN amplified_VBN from_IN total_JJ
          RNA_NNP on_IN different_JJ days_NNS ._. The_DT reproducibility_NN of_IN our_PRP$
          protocol_NN is_VBZ slightly_RB better_JJR than_IN that_DT using_VBG other_JJ
          protocols_NNS ._. Notably_RB ,_, when_WRB samples_NNS are_VBP amplified_VBN on_IN the_DT
          same_JJ day_NN ,_, the_DT correlations_NNS are_VBP significantly_RB higher_JJR than_IN
          when_WRB samples_NNS are_VBP amplified_VBN on_IN different_JJ days_NNS ._. In_IN
          addition_NN ,_, samples_NNS amplified_VBN with_IN protocols_NNS omitting_VBG
          ligase_NN activity_NN give_VB higher_JJR reproducibility_NN regardless_RB of_IN
          whether_IN they_PRP are_VBP amplified_VBN on_IN the_DT same_JJ day_NN or_CC not_RB ._.
        
        
          The_DT effect_NN of_IN the_DT amount_NN of_IN input_NN total_JJ RNA_NNP on_IN
          amplification_NN
          To_TO determine_VB the_DT effect_NN of_IN the_DT amount_NN of_IN input_NN total_JJ
          RNA_NNP on_IN single_JJ round_NN amplification_NN ,_, we_PRP amplified_VBN different_JJ
          amounts_NNS of_IN total_JJ RNA_NNP ,_, 3_CD μg_NN ,_, 1_CD μg_NN ,_, 300_CD ng_NN ,_, 100_CD ng_NN ,_, 30_CD ng_NN
          and_CC 10_CD ng_NN ,_, using_VBG different_JJ amounts_NNS of_IN T_NN 7_CD primer_NN according_VBG
          to_TO the_DT quantity_NN of_IN input_NN total_JJ RNA_NNP (_( Table_NNP 9_CD )_) ._. When_WRB the_DT
          input_NN total_JJ RNA_NNP is_VBZ lower_JJR than_IN 300_CD ng_NN ,_, the_DT yield_NN of_IN aRNA_NN
          for_IN is_VBZ lower_JJR than_IN the_DT standard_JJ quantity_NN required_VBN for_IN one_CD
          hybridization_NN (_( 3_CD μg_NN )_) ._. At_IN amounts_NNS greater_JJR or_CC equal_JJ to_TO 300_CD
          ng_NN ,_, the_DT correlation_NN coefficients_NNS between_IN amplified_VBN and_CC
          unamplified_JJ samples_NNS and_CC among_IN amplified_VBN samples_NNS remain_VBP
          about_IN the_DT same_JJ ._. The_DT fold_VB of_IN amplification_NN increases_NNS with_IN
          smaller_JJR quantities_NNS of_IN template_NN RNA_NNP ,_, but_CC the_DT absolute_JJ
          yield_NN of_IN aRNA_NN decreases_NNS ._. Therefore_RB ,_, within_IN the_DT range_NN of_IN
          0_CD ._. 3_CD -_: 3_CD μg_NN total_JJ RNA_NNP ,_, decreasing_VBG the_DT input_NN RNA_NNP does_VBZ not_RB
          affect_VB the_DT fidelity_NN and_CC reproducibility_NN of_IN
          amplification_NN ._.
          All_DT original_JJ microarray_NN data_NNS may_MD be_VB accessed_JJ at_IN the_DT
          RNA_NNP Amplification_NNP for_IN Microarrays_NNP website_NN
          http_NN :_: /_NN /_NN genome-www_JJ ._. stanford_NN ._. edu_NN /_NN breast_NN __NN cancer_NN /_NN amplification_NN /_NN ._.
        
      
      
        Conclusions_NNP
        In_IN conclusion_NN ,_, T_NN 7_CD based_VBN linear_JJ amplification_NN generates_VBZ
        high_JJ fidelity_NN aRNA_NN for_IN gene_NN expression_NN profiling_VBG using_VBG
        high-density_JJ cDNA_NN microarrays_NNS ._. The_DT average_JJ correlation_NN
        coefficient_NN between_IN amplified_VBN and_CC unamplified_JJ samples_NNS is_VBZ
        0_CD ._. 82_CD with_IN less_JJR than_IN 4_CD %_NN of_IN genes_NNS showing_VBG changes_NNS in_IN
        expression_NN level_NN by_IN 2_CD -_: fold_VB or_CC greater_JJR using_VBG the_DT optimized_JJ
        (_( Jeffrey_NNP lab_NN )_) protocol_NN ._. The_DT correlation_NN to_TO unamplified_JJ
        poly_RB (_( A_DT )_) +_NN RNA_NNP increases_NNS to_TO 0_CD ._. 85_CD when_WRB experimental_JJ
        variability_NN is_VBZ minimized_VBN by_IN configuring_VBG multiple_JJ amplified_VBN
        samples_NNS into_IN a_DT virtual_JJ array_NN ._. Reproducibility_NNP between_IN
        samples_NNS amplified_VBN with_IN this_DT technique_NN is_VBZ high_JJ ,_, especially_RB
        when_WRB performed_VBN on_IN the_DT same_JJ day_NN rather_RB than_IN weeks_NNS apart_RB ._.
        Amplification_NNP produces_VBZ a_DT dampening_VBG effect_NN on_IN gene_NN
        expression_NN variation_NN ._.
      
      
        Methods_NNP
        
          Tissue_NNP acquisition_NN
          Two_CD primary_JJ breast_NN carcinomas_NNS ,_, BC_NNP 2_CD and_CC BC_NNP 91_CD ,_, in_IN which_WDT
          more_JJR than_IN 90_CD %_NN of_IN the_DT breast_NN epithelial_NN cells_NNS were_VBD cancer_NN
          cells_NNS ,_, were_VBD chosen_VBN for_IN experiments_NNS in_IN this_DT study_NN ._. The_DT
          specimens_NNS were_VBD frozen_VBN in_IN either_DT liquid_JJ nitrogen_NN (_( BC_NNP 2_LS )_) or_CC
          on_IN dry_JJ ice_NN (_( BC_NNP 91_CD )_) within_IN 30_CD minutes_NNS following_VBG
          devascularization_NN and_CC stored_VBD at_IN -_: 80_CD °_NN C_NNP ._. Frozen_NNP sections_NNS
          were_VBD cut_VBN from_IN primary_JJ breast_NN carcinoma_NN specimens_NNS and_CC
          stained_JJ with_IN hematoxylin_NN and_CC eosin_NN to_TO confirm_VB tumor_NN
          content_NN ._.
        
        
          RNA_NNP preparation_NN
          Total_NNP RNA_NNP was_VBD isolated_VBN from_IN primary_JJ tumor_NN tissue_NN using_VBG
          TRIzol_NNP ®_NN solution_NN (_( Invitrogen_NNP ™_NN )_) following_VBG homogenization_NN
          using_VBG a_DT PowerGen_NNP Model_NNP 125_CD (_( Fisher_NNP Scientific_NNP )_) ._. Poly_NNP (_( A_DT )_)
          +_NN RNA_NNP was_VBD isolated_VBN from_IN total_JJ RNA_NNP with_IN the_DT FastTrack_NNP 2_CD ._. 0_CD
          kit_NN (_( Invitrogen_NNP ™_NN )_) ._. The_DT concentration_NN of_IN total_JJ RNA_NNP and_CC
          poly_RB (_( A_DT )_) +_NN RNA_NNP was_VBD determined_VBN using_VBG a_DT GeneSpec_NNP I_PRP
          spectrophotometer_NN (_( Hitachi_NNP )_) and_CC the_DT integrity_NN of_IN total_JJ
          RNA_NNP and_CC poly_RB (_( A_DT )_) +_NN RNA_NNP was_VBD assessed_VBN using_VBG a_DT 2100_CD
          Bioanalyzer_NNP (_( Agilent_NNP )_) ._.
        
        
          RNA_NNP amplification_NN
          The_DT amplification_NN of_IN total_JJ RNA_NNP or_CC poly_RB (_( A_DT )_) +_NN RNA_NNP was_VBD
          performed_VBN based_VBN on_IN a_DT previously_RB described_VBN protocol_NN [_NN 24_CD ]_NN
          with_IN our_PRP$ modifications_NNS ._.
          For_IN first_JJ strand_NN cDNA_NN synthesis_NN ,_, 3_CD μg_NN (_( unless_IN
          otherwise_RB specified_VBN )_) tumor_NN total_JJ RNA_NNP ,_, Universal_NNP Human_NNP
          Reference_NNP total_JJ RNA_NNP (_( Stratagene_NNP ®_NN )_) ,_, or_CC 150_CD ng_NN poly_RB (_( A_DT )_)
          +_NN RNA_NNP was_VBD mixed_VBN with_IN 1_CD μg_NN Eberwine_NNP primer_NN (_( Operon_NNP ®_NN )_) in_IN
          RNase-free_NNP water_NN to_TO a_DT total_JJ volume_NN of_IN 9_CD μl_NN ._. The_DT
          RNA_NNP /_NN primer_NN mixture_NN was_VBD denatured_JJ at_IN 70_CD °_NN C_NNP for_IN 3_CD min_NN and_CC
          cooled_VBN on_IN ice_NN for_IN 2_CD min_NN ,_, followed_VBN by_IN adding_VBG :_: 4_CD μl_NN of_IN 5_CD X_NNP
          first_JJ strand_NN buffer_NN (_( Invitrogen_NNP ™_NN )_) ,_, 2_CD μl_NN 0_CD ._. 1_CD M_NNP DTT_NNP ,_, 1_CD μl_NN
          RNasin_NNP ®_NN (_( 40_CD U_NNP /_NN μl_NN ,_, Promega_NNP ™_NN )_) ,_, 2_CD μl_NN 10_CD mM_NN dNTP_NN ,_, and_CC 2_CD μl_NN
          Superscript_NNP ™_NN II_NNP (_( 200_CD U_NNP /_NN μl_NN ,_, Invitrogen_NNP ™_NN )_) ,_, and_CC incubated_JJ at_IN
          42_CD °_NN C_NNP for_IN 1_CD ._. 5_CD hours_NNS ._.
          Second_JJ strand_NN cDNA_NN synthesis_NN was_VBD performed_VBN by_IN mixing_VBG
          the_DT first_JJ strand_NN synthesis_NN reaction_NN with_IN 106_CD μl_NN
          RNase-free_NNP water_NN ,_, 15_CD μl_NN 10_CD X_NNP Advantage_NNP ™_NN PCR_NNP buffer_NN
          (_( Clontech_NNP )_) ,_, 3_CD μl_NN 10_CD mM_NN dNTP_NN mix_NN ,_, 3_CD μl_NN Advantage_NNP ™_NN cDNA_NN
          polymerase_NN mix_NN (_( Clontech_NNP )_) ,_, and_CC 1_CD μl_NN RNase_NNP H_NNP (_( 2_CD U_NNP /_NN μl_NN ,_,
          Invitrogen_NNP ™_NN )_) ._. The_DT reaction_NN was_VBD incubated_JJ at_IN 37_CD °_NN C_NNP for_IN 5_CD
          min_NN to_TO digest_VB RNA_NNP ,_, followed_VBN by_IN 94_CD °_NN C_NNP for_IN 2_CD min_NN to_TO activate_VBP
          the_DT Advantage_NNP ™_NN cDNA_NN polymerase_NN ,_, 65_CD °_NN C_NNP for_IN 1_CD min_NN to_TO prime_JJ
          and_CC 75_CD °_NN C_NNP for_IN 30_CD min_NN to_TO extend_VB the_DT second_JJ strand_NN cDNA_NN ._. The_DT
          reaction_NN was_VBD stopped_VBN by_IN the_DT addition_NN of_IN 7_CD ._. 5_CD μl_NN 1_CD M_NNP NaOH_NNP /_NN 2_CD
          mM_NN EDTA_NNP and_CC incubated_JJ at_IN 65_CD °_NN C_NNP for_IN 10_CD min_NN ._.
          ds_NNS cDNA_NN was_VBD extracted_VBN with_IN an_DT equal_JJ volume_NN of_IN
          phenol_NN :_: chloroform_NN :_: isoamyl_NN alcohol_NN (_( 25_CD :_: 24_CD :_: 1_LS )_) ,_, transferred_VBN
          to_TO a_DT Phase_NN Lock_NNP Gel_NNP ™_NN tube_NN (_( Eppendorf_NNP )_) and_CC centrifuged_JJ at_IN
          16_CD ,_, 000_CD g_SYM for_IN 5_CD min_NN ._. The_DT ds_NNS cDNA_NN (_( aqueous_JJ layer_NN )_) was_VBD
          transferred_VBN to_TO a_DT new_JJ tube_NN and_CC precipitated_VBD by_IN adding_VBG 1_CD μl_NN
          linear_JJ acrylamide_NN (_( 0_CD ._. 1_LS μg_NN /_NN μl_NN )_) ,_, 70_CD μl_NN 7_CD ._. 5_CD M_NNP NH_NNP 
          4_CD Ac_NNP and_CC 1_CD ml_NN 200_CD proof_NN ethanol_NN ,_, and_CC
          centrifuged_JJ at_IN 16_CD ,_, 000_CD g_SYM for_IN 20_CD min_NN at_IN room_NN temperature_NN ._.
          The_DT pellet_NN was_VBD washed_VBN in_IN 500_CD μl_NN 75_CD %_NN ethanol_NN ,_, centrifuged_JJ
          at_IN 16_CD ,_, 000_CD g_SYM for_IN 5_CD min_NN ,_, air_NN dried_VBD and_CC resuspended_JJ in_IN 16_CD μl_NN
          RNase-free_NNP water_NN ._.
          In_IN vitro_NN transcription_NN of_IN ds_NNS cDNA_NN was_VBD performed_VBN using_VBG
          a_DT T_NN 7_CD MEGAscript_NNP ™_NN kit_NN (_( Ambion_NNP ®_NN )_) ._. Four_CD microliters_NNS of_IN each_DT
          75_CD mM_NN NTP_NNP ,_, 4_CD μl_NN of_IN 10_CD X_NNP reaction_NN buffer_NN and_CC 4_CD μl_NN of_IN T_NN 7_CD
          polymerase_NN mix_NN was_VBD added_VBN to_TO the_DT 16_CD μl_NN of_IN ds_NNS cDNA_NN ._. The_DT
          reaction_NN was_VBD then_RB carried_VBN out_RB at_IN 37_CD °_NN C_NNP for_IN 5_CD hours_NNS ._. aRNA_NN
          was_VBD cleaned_VBN up_RP using_VBG an_DT RNeasy_NNP ®_NN mini_NN kit_NN (_( Qiagen_NNP ®_NN )_) as_IN
          described_VBN by_IN the_DT manufacturer_NN ._.
          The_DT optimized_JJ version_NN of_IN the_DT amplification_NN protocol_NN
          may_MD also_RB be_VB downloaded_JJ from_IN
          http_NN :_: /_NN /_NN www_NN ._. stanford_NN ._. edu_NN /_NN group_NN /_NN sjeffreylab_NN /_NN ._.
        
        
          RNA_NNP labelling_VBG and_CC hybridization_NN
          Three_CD micrograms_NNS of_IN aRNA_NN (_( unless_IN otherwise_RB specified_VBN )_)
          or_CC 2_CD μg_NN poly_RB (_( A_DT )_) +_NN RNA_NNP were_VBD labelled_JJ either_CC with_IN Cy_NNP 5_CD -_: dUTP_NN
          (_( experimental_JJ sample_NN )_) or_CC Cy_NNP 3_CD -_: dUTP_NN (_( reference_NN )_) in_IN a_DT 30_CD ._. 4_LS
          μl_NN reaction_NN ._. RNA_NNP was_VBD first_JJ mixed_VBN with_IN either_DT 8_CD μg_NN of_IN
          random_JJ primer_NN for_IN aRNA_NN or_CC 5_CD μg_NN of_IN oligo_NN (_( dT_NN )_) primer_NN for_IN
          poly_RB (_( A_DT )_) +_NN RNA_NNP in_IN 16_CD μl_NN of_IN RNase-free_NNP water_NN ._. RNA_NNP /_NN primer_NN mix_NN
          was_VBD incubated_JJ at_IN 70_CD °_NN C_NNP for_IN 10_CD min_NN and_CC cooled_VBN on_IN ice_NN for_IN 2_CD
          min_NN ._. The_DT following_VBG reagents_NNS were_VBD added_VBN :_: 6_CD μl_NN of_IN 5_CD X_NNP first_JJ
          strand_NN buffer_NN ,_, 3_CD μl_NN 0_CD ._. 1_CD M_NNP DTT_NNP ,_, 0_CD ._. 7_CD μl_NN 50_CD X_NNP dNTP_NN (_( 25_CD mM_NN
          dATP_NN ,_, dCTP_NN ,_, dGTP_NN and_CC 10_CD mM_NN dTTP_NN )_) ,_, 3_CD μl_NN 1_CD mM_NN Cy_NNP 3_CD -_: dUTP_NN or_CC
          Cy_NNP 5_CD -_: dUTP_NN and_CC 1_CD ._. 7_CD μl_NN Superscript_NNP ™_NN II_NNP (_( 200_CD U_NNP /_NN μl_NN )_) ._. The_DT
          labelling_VBG reaction_NN was_VBD carried_VBN out_RB at_IN 42_CD °_NN C_NNP for_IN 2_CD hour_NN
          during_IN which_WDT 1_CD μl_NN Superscript_NNP ™_NN II_NNP was_VBD added_VBN to_TO the_DT
          reaction_NN at_IN the_DT end_NN of_IN the_DT first_JJ hour_NN ._. The_DT input_NN RNA_NNP was_VBD
          hydrolyzed_JJ by_IN adding_VBG 15_CD μl_NN 0_CD ._. 1_CD M_NNP NaOH_NNP /_NN 2_CD mM_NN EDTA_NNP and_CC
          incubated_JJ at_IN 65_CD °_NN C_NNP for_IN 8_CD min_NN ,_, followed_VBN by_IN neutralization_NN
          with_IN 15_CD μl_NN 0_CD ._. 1_CD M_NNP HCl_NNP ._. The_DT Cy_NNP 5_CD and_CC Cy_NNP 3_CD labelled_JJ probes_NNS
          were_VBD combined_VBN and_CC purified_JJ in_IN a_DT Microcon_NNP ®_NN YM-_NNP 30_CD column_NN
          (_( Millipore_NNP )_) by_IN washing_VBG three_CD times_NNS with_IN Tris-_NNP EDTA_NNP buffer_NN ._.
          15_CD μg_NN Human_NNP Cot-_NNP 1_CD DNA_NNP was_VBD added_VBN to_TO the_DT probe_NN before_IN the_DT
          first_JJ wash_NN ._. The_DT purified_JJ probe_NN was_VBD adjusted_VBN to_TO a_DT total_JJ
          volume_NN of_IN 26_CD μl_NN and_CC mixed_VBN with_IN 5_CD ._. 3_CD μl_NN 20_CD X_NNP saline-sodium_JJ
          citrate_NN (_( SSC_NNP )_) ,_, 1_CD μl_NN yeast_NN tRNA_NN (_( 10_CD μg_NN /_NN μl_NN )_) ,_, 2_CD μl_NN poly_RB (_( A_DT )_)
          DNA_NNP (_( 10_CD μg_NN /_NN μl_NN )_) ,_, and_CC 0_CD ._. 6_CD μl_NN 10_CD %_NN sodium_NN dodecyl_NN sulfate_NN
          (_( SDS_NNP )_) ._. The_DT resulting_VBG 35_CD μl_NN probe_NN solution_NN was_VBD denatured_JJ
          at_IN 95_CD °_NN C_NNP for_IN 2_CD min_NN and_CC then_RB incubated_JJ at_IN 42_CD °_NN C_NNP for_IN 25_CD min_NN ._.
          The_DT probe_NN was_VBD then_RB hybridized_JJ to_TO cDNA_NN arrays_NNS at_IN 65_CD °_NN C_NNP for_IN
          14_CD -_: 18_CD hours_NNS ._. Depending_VBG on_IN the_DT print_NN batch_NN ,_, the_DT arrays_NNS
          contained_VBD from_IN 42_CD ,_, 772_CD to_TO 43_CD ,_, 915_CD spots_NNS (_( 41_CD ,_, 931_CD -_: 42_CD ,_, 602_CD
          distinct_JJ clones_NNS representing_VBG 16_CD ,_, 907_CD -_: 18_CD ,_, 417_CD named_VBN genes_NNS ,_,
          3946_CD -_: 4145_CD ESTs_NNP with_IN known_VBN functions_NNS and_CC 19_CD ,_, 369_CD -_: 21_CD ,_, 384_CD
          ESTs_NNP with_IN unknown_JJ functions_NNS )_) ,_, and_CC were_VBD manufactured_VBN as_RB
          previously_RB described_VBD [_NN 31_CD 32_CD 33_CD ]_NN ._. Following_VBG
          hybridization_NN ,_, the_DT arrays_NNS were_VBD washed_VBN with_IN 2_CD X_NNP SSC_NNP with_IN
          0_CD ._. 05_CD %_NN SDS_NNP once_RB for_IN 2_CD min_NN at_IN room_NN temperature_NN ,_, 1_CD X_NNP SSC_NNP for_IN
          2_CD min_NN at_IN room_NN temperature_NN ,_, 0_CD ._. 2_CD X_NNP SSC_NNP three_CD times_NNS for_IN 1_CD min_NN
          at_IN 45_CD -_: 50_CD °_NN C_NNP ._.
        
        
          Imaging_NNP and_CC data_NNS analysis_NN
          The_DT arrays_NNS with_IN hybridized_JJ probes_NNS were_VBD scanned_JJ using_VBG
          an_DT Axon_NNP scanner_NN ._. The_DT scanned_JJ images_NNS were_VBD analyzed_VBN first_JJ
          using_VBG GenePix_NNP ®_NN Pro_FW 3_CD ._. 0_CD software_NN (_( Axon_NNP Instruments_NNP )_) and_CC
          spots_NNS of_IN poor_JJ quality_NN determined_VBN by_IN visual_JJ inspection_NN
          were_VBD also_RB removed_VBN from_IN further_JJ analysis_NN ._. The_DT resulting_VBG
          data_NN collected_VBN from_IN each_DT array_NN was_VBD submitted_VBN to_TO the_DT
          Stanford_NNP Microarray_NNP Database_NNP (_( SMD_NNP ,_,
          http_NN :_: /_NN /_NN genome-www_JJ 5_CD ._. stanford_NN ._. edu_NN /_NN microarray_NN /_NN SMD_NNP )_) [_NN 34_CD ]_NN ._.
          A_DT total_NN of_IN 97_CD arrays_NNS were_VBD submitted_VBN (_( 60_CD experiments_NNS done_VBN
          with_IN BC_NNP 2_CD and_CC 37_CD experiments_NNS performed_VBN with_IN BC_NNP 91_CD )_) ._. Only_RB
          features_VBZ with_IN a_DT signal_NN intensity_NN >_NN 50_CD %_NN above_IN background_NN
          in_IN both_DT Cy_NNP 5_CD and_CC Cy_NNP 3_CD channels_NNS for_IN all_DT of_IN the_DT samples_NNS
          included_VBN in_IN a_DT particular_JJ analysis_NN were_VBD retrieved_VBN from_IN
          SMD_NNP ._. Pearson_NNP 's_POS correlation_NN coefficient_NN was_VBD calculated_VBN
          using_VBG Microsoft_NNP ®_NN Excel_NNP 2000_CD ._. A_DT components_NNS of_IN variance_NN
          model_NN was_VBD used_VBN to_TO explain_VB different_JJ sources_NNS of_IN variation_NN
          in_IN the_DT amplification_NN protocols_NNS ._.
        
      
      
        Authors_NNP '_'' contributions_NNS
        HZ_NNP participated_VBD in_IN study_NN design_NN ,_, isolated_VBD the_DT RNA_NNP ,_,
        performed_VBD all_PDT the_DT amplification_NN and_CC hybridization_NN
        experiments_NNS ,_, participated_VBD in_IN data_NNS analysis_NN ,_, and_CC drafted_VBD the_DT
        manuscript_NN ._. TH_NNP performed_VBD the_DT statistical_JJ analyses_NNS and_CC
        drafted_VBD the_DT statistical_JJ portions_NNS of_IN the_DT manuscript_NN ._. MW_NNP
        participated_VBD in_IN study_NN design_NN and_CC editing_NN of_IN the_DT manuscript_NN ._.
        ALBD_NNP participated_VBD in_IN data_NNS analysis_NN and_CC editing_NN of_IN the_DT
        manuscript_NN ._. SSJ_NNP conceived_VBD of_IN the_DT study_NN ,_, guided_VBD its_PRP$ design_NN
        and_CC coordination_NN ,_, participated_VBD in_IN data_NNS analysis_NN ,_, drafted_VBN
        portions_NNS of_IN the_DT manuscript_NN ,_, and_CC supervised_JJ editing_NN ._.
        All_DT authors_NNS read_VBP and_CC approved_VBD the_DT final_JJ manuscript_NN ._.
      
    
  
